Iran’s Health Ministry announced in a statement on Monday that the country’s daily COVID-19 deaths and infections reached 181 and 11,844, respectively, in the past 24 hours.
It said the total COVID-19 death toll and infections since the beginning of the outbreak in the country in late February 2020 stand at 124,256 and 5,796,659, respectively.
According to the ministry, 4,693 COVID-19 patients are in critical condition, and of the newly-detected cases, 1,804 individuals have been hospitalized.
It added 5,333,304 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.
The statement added 34,115,587 coronavirus diagnostic tests have so far been carried out in the country and 74,113,680 doses of COVID vaccines have been administered, of which 1,470,158 doses were given to people in the past 24 hours.
The Health Ministry said nine cities in the country are coded red (very high-risk), while 106 are in the orange zone (high-risk).
The number of the country’s yellow (medium-risk) and blue (low-risk) cities are 228 and 105, respectively, according to the ministry.
Iran was grappling with a fifth wave of the COVID-19 pandemic over the past few months, mainly sparked by the spread of the Indian coronavirus variant, known as Delta, seeing a resurgence in deaths and infections. The number of casualties has, however, been declining since a few weeks ago, indicating that the country is past the peak of the fifth wave’s infections and deaths.
Of great contribution to the decline in Iran’s daily COVID deaths and infections has been the greater momentum of the public vaccination process over the past weeks on the back of the rise in imports and domestic production of vaccines.
The country has received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN), and has also developed a number of COVID jabs domestically including one dubbed COVIran Barekat (Barakat Foundation), a jab named Soberana 2, or PastoCoVac (Cuba’s Instituto Finlay de Vacunas and Iran’s Pasteur Institute) and a vaccine known as Fakhra (Defense Ministry).
The other two COVID jabs being developed in the country are Noura (the Islamic Revolution Guards Corps) and Razi Cov Pars (Razi Vaccine and Serum Research Institute).